In vitro validation of an ultra-sensitive scanning fluorescence microscope for analysis of circulating tumor cells

APMIS

Volumn 122, Issue 6, 2014, Pages 545-551

  Hillig, Thore ^a   Nygaard, Ann Britt ^a   Nekiunaite, Laura ^a   Klingelhöfer, Jörg ^b   Sölétormos, György ^a  

^a HILLERØD HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cancer; Circulating tumor cells; CTC; CytoTrack

Indexed keywords

ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CIRCULATING TUMOR CELL; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; MCF 7 CELL LINE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

CANCER; CIRCULATING TUMOR CELLS; CTC; CYTOTRACK;

ANTIGENS, CD45; BREAST NEOPLASMS; CELL COUNT; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; FLUORESCENT DYES; HUMANS; INDOLES; KERATINS; MCF-7 CELLS; MICROSCOPY, FLUORESCENCE; NEOPLASTIC CELLS, CIRCULATING;

EID: 84901198004     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/apm.12183     Document Type: Article

References (24)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Eccles SA, Welch DR. Metastasis: recent discoveries and novel treatment strategies. Lancet 2007;369:1742-57.
3. Ashworth TR. A case of cancer in which cells similar to those in the tumors were seen in the blood after death. Australian Med J 1869;14:146-7.
4. Armakolas A, Panteleakou Z, Nezos A, Tsouma A, Skondra M, Lembessis P, et al. Detection of the circulating tumor cells in cancer patients. Future Oncol 2010;6:1849-56.
5. Mavroudis D. Circulating cancer cells. Ann Oncol 2010;21(Suppl 7):vii95-100.
6. Budd GT, Cristofanilli M, Ellis MJ, Stopeck A, Borden E, Miller MC, et al. Circulating tumor cells versus imaging-predicting overall survival in metastatic breast cancer. Clin Cancer Res 2006;12:6403-9.
7. Cristofanilli M, Hayes DF, Budd GT, Ellis MJ, Stopeck A, Reuben JM, et al. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 2005;23:1420-30.
8. De Giorgi U, Valero V, Rohren E, Dawood S, Ueno NT, Miller MC, et al. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer. J Clin Oncol 2009;27:3303-11.
9. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004;351:781-91.
10. Attard G, Swennenhuis JF, Olmos D, Reid AH, Vickers E, A'Hern R, et al. Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer. Cancer Res 2009;69:2912-8.
11. Yen LC, Yeh YS, Chen CW, Wang HM, Tsai HL, Lu CY, et al. Detection of KRAS oncogene in peripheral blood as a predictor of the response to cetuximab plus chemotherapy in patients with metastatic colorectal cancer. Clin Cancer Res 2009;15:4508-13.
12. Gerges N, Rak J, Jabado N. New technologies for the detection of circulating tumour cells. Br Med Bull 2010;94:49-64.
13. Sun YF, Yang XR, Zhou J, Qiu SJ, Fan J, Xu Y. Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance. J Cancer Res Clin Oncol 2011;137:1151-73.
14. Lianidou ES, Markou A. Circulating tumor cells as emerging tumor biomarkers in breast cancer. Clin Chem Lab Med 2011;49:1579-90.
15. Miller MC, Doyle GV, Terstappen LW. Significance of circulating tumor cells detected by the Cell Search system in patients with metastatic breast colorectal and prostate cancer. J Oncol 2010;2010:617421.
16. Riethdorf S, Fritsche H, Muller V, Rau T, Schindlbeck C, Rack B, et al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the Cell Search system. Clin Cancer Res 2007;13:920-8.
17. Lianidou ES, Markou A. Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges. Clin Chem 2011;57:1242-55.
18. D'Agostino RB, Pearson E. Tests of departure from normality. Empirical results for the distribution of b2 and √b1. Biometrika 1973;60:613-22.
19. Effenberger KE, Borgen E, Eulenburg CZ, Bartkowiak K, Grosser A, Synnestvedt M, et al. Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern. Breast Cancer Res Treat 2011;125:729-38.
20. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 2004;10:6897-904.
21. Marrinucci D, Bethel K, Kolatkar A, Luttgen MS, Malchiodi M, Baehring F, et al. Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers. Phys Biol 2012;9:016003.
22. Gratama JW, Menendez P, Kraan J, Orfao A. Loss of CD34(+) hematopoietic progenitor cells due to washing can be reduced by the use of fixative-free erythrocyte lysing reagents. J Immunol Methods 2000;239:13-23.
23. - objects predict overall survival in castration-resistant prostate cancer. Ann Oncol 2010;21:1851-7.
24. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008;133:704-15.